ASPG and sarcoma: Asparagine depletion of sarcoma cells can also be achieved by exposure to asparaginase (N-ase), an U.S. Food and Drug Administration (FDA)-approved drug which catalyzes the breakdown of asparagine and glutamine in medium with and without cells (Figure 5a) [16].